ASSETMARK, INC

Position in HCM — HUTCHMED (China) Ltd

CIK 1344551 CONCORD, CA

Position in HCM

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$8,737

+$5,940 QoQ

Shares Held

812

+334.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#36

of 56 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ASSETMARK, INC holds $375,029,634 across 23 Drug Manufacturers - Specialty & Generic names. HCM ranks #16 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	624,068	$338,138,764
2	ZTS	Zoetis Inc.	282,029	$20,266,603
3	TAK	Takeda Pharmaceutical Co Ltd	314,687	$5,044,432
4	NBIX	Neurocrine Biosciences Inc	16,414	$2,766,415
5	TEVA	Teva Pharmaceutical Industries Ltd	81,250	$2,752,750
6	SUPN	Supernus Pharmaceuticals, Inc.	49,713	$2,312,151
7	AMPH	Amphastar Pharmaceuticals, Inc.	68,590	$1,384,146
8	LNTH	Lantheus Holdings, Inc.	12,110	$1,343,483

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,737	812	+334.2%	Shares	Sole	2026-07-30
2026-03-31	$2,797	187	+392.1%	Shares	Sole	2026-05-06
2025-12-31	$506	38	+153.3%	Shares	Sole	2026-01-23
2025-09-30	$236	15	0.0%	Shares	Sole	2025-11-06
2025-06-30	$225	15	-80.0%	Shares	Sole	2025-08-04
2022-09-30	$664	75	-63.1%	Shares	Sole	2022-11-01
2022-06-30	$2,565	203	-90.4%	Shares	Sole	2022-08-03
2022-03-31	$40,129	2,121	+65.3%	Shares	Sole	2022-05-13
2021-12-31	$45,007	1,283	+55.3%	Shares	Sole	2022-02-14
2021-09-30	$30,239	826	+5.4%	Shares	Sole	2021-11-12
2021-06-30	$30,787	784	0.0%	Shares	Sole	2021-08-16
2021-03-31	$22,148	784	0.0%	Shares	Sole	2021-05-14
2020-12-31	$25,103	784	0.0%	Shares	Sole	2021-02-10
2020-09-30	$25,323	784	+27.3%	Shares	Sole	2020-11-13
2020-06-30	$16,989	616	+4.4%	Shares	Sole	2020-08-11
2020-03-31	$10,531	590	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.